Delta-Fly Pharma, Inc.TSE: 4598

Announcement Regarding Patent Allowance for a Long-Term Stable Formulation of DFP-10917

· Issued by Delta-Fly Pharma, Inc. via TDnet

Filed with TSE · · 1 page · English

Summary by 6ix AI

This novel manufacturing process significantly improves stability compared to the conventional formulation, achieving over five years of stability at industrial scale. The company believes this advancement will aid in discussions with regulatory authorities regarding future approvals and clinical trials.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Delta-Fly Pharma, Inc. on 6ix

Earlier from Delta-Fly Pharma

All Delta-Fly Pharma news releases